Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction
Abstract The objective of this study is to explore whether procalcitonin (PCT) can serve as an early biomarker of malignant cerebral edema in patients with massive cerebral infarction (MCI). Ninety-three patients with acute MCI were divided into death or survival groups based on whether they died or...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2018-01-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-018-19267-4 |